There was a significant association between poor PFS and positive serum HGF 1–2 months after starting treatment p < 0.01. In patients with adenocarcinoma treated with second line chemotherapy, high HGF pre-treatment 1–2 months after treatment was associated with poor PFS (p < 0.01). Here, HGF is linked to adenocarcinoma.